From: Diabetic kidney disease in patients with type 2 diabetes mellitus: a cross-sectional study
Variable | Subgroups | Beta coefficient | 95% CI | p value |
---|---|---|---|---|
Sex | Female (Ref) | |||
Male | −0.2 | −0.41–0.1 | 0.24 | |
Age (Years) (continuous) | 0.06 | 0.05–0.07 | <0.01* | |
Duration of DM (Y) (continuous) | 0.02 | 0.01–0.03 | 0.04* | |
Medical history | Smoking | −0.5 | − 0.21–0.12 | 0.6 |
Hypertension | 0.23 | −0.07–0.54 | 0.13 | |
CAD | 0.12 | −0.23–0.73 | 0.5 | |
Stroke | 0.32 | − 0.1–0.7 | 0.13 | |
Neuropathy | −0.1 | −0.33–0.14 | 0.4 | |
Retinopathy | 0.27 | 0.02–0.5 | 0.04* | |
Medications | Insulin | 0.06 | −0.2–0.31 | 0.65 |
Metformin | −1.34 | −1.6–-1.1 | <0.01* | |
ACEIs/ARBs | −0.31 | − 0.56–-0.10 | <0.01* | |
Beta blockers | 0.35 | 0.1–0.6 | <0.01* | |
Diuretics | 0.6 | 0.33–0.85 | <0.01* | |
CCB | 0.7 | 0.44–1 | <0.01* | |
Triglyceride level (mg/dl) | 0.01 | 0.0001–0.02 | <0.01* |